Picture

Questions?

+1-866-353-3335

SEARCH
What are you looking for?
Need help finding what you are looking for? Contact Us
Compare

PUBLISHER: SkyQuest | PRODUCT CODE: 1458102

Cover Image

PUBLISHER: SkyQuest | PRODUCT CODE: 1458102

Global Stem Cell Therapy Market Size, Share, Growth Analysis, By Therapy(Autologous, and Allogenic), By Application(Regenerative Medicine, Drug Discovery and Development) - Industry Forecast 2024-2031

PUBLISHED:
PAGES: 219 Pages
DELIVERY TIME: 3-5 business days
SELECT AN OPTION
PDF & Excel (Single User License)
USD 5300
PDF & Excel (Multiple User License)
USD 6200
PDF & Excel (Enterprise License)
USD 7100

Add to Cart

Global Stem cell therapy Market size was valued at USD 12.11 Billion in 2022 and is poised to grow from USD 13.33 Billion in 2023 to USD 28.79 Billion by 2031, at a CAGR of 10.1% during the forecast period (2024-2031).

The main goal of the stem cell therapy industry is to offer cutting-edge solutions for a variety of illnesses. The goal of stem cell therapies is to treat illnesses and injuries for which there are currently few or no effective therapy alternatives. This market aims to give patients with ailments like cardiovascular diseases, neurological disorders, orthopedic injuries, autoimmune diseases, and some kinds of cancer hope by utilizing the regenerative characteristics of stem cells. the expansion of the market for stem cell therapy worldwide. The rising incidence of age-related illnesses and chronic disorders is one of the main causes.

The high price of stem cell treatments is one of the main obstacles. Numerous obstacles confront the market for stem cell therapy. The requirement for regulation and standardization is one of the main obstacles. Establishing precise norms and standards for stem cell therapy development, manufacturing, and clinical application is becoming more and more important as these treatments progress. Cost-effectiveness and scalability are two issues the market is facing. One major obstacle that still needs to be overcome is increasing the production of stem cell therapies to satisfy demand while keeping quality and costs down. Despite the difficulties, the market for stem cell therapy presents a lot of potential. A bright future is suggested by the growing number of clinical trials and research investigations examining the potential of stem cell therapy.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Stem Cell Therapy Market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Stem Cell Therapy Market Segmental Analysis

The therapy, application, and geographic segments of the worldwide stem cell therapy market are divided up. The market is divided into two categories for therapy: autologous and allogeneic. The market is divided into three categories based on application: drug development, regenerative medicine, and discovery. The market is divided into Latin America, Middle East and Africa, Asia Pacific, North America, and Europe.

Drivers of the Global Stem Cell Therapy Market

One major factor propelling the stem cell therapy market is the increasing prevalence of chronic diseases like neurological illnesses, orthopedic injuries, and cardiovascular ailments. With the ability to repair damaged tissues and organs, stem cell therapies offer patients new therapy options when there are few or no other viable options.

Restraints in the Global Stem Cell Therapy Market

One major obstacle to the broad acceptance of stem cell therapies is their high cost. The cost of these treatments is considerable due in part to the complexity of manufacturing, research and development activities, and regulatory restrictions. This restricts many patients' access to stem cell treatments, especially in areas with lower incomes.

Market Trends of the Global Stem Cell Therapy Market

A greater emphasis is being placed on allogeneic therapies: these treatments, which employ donor cells, have become more popular. Benefits of this technique include lower production costs, uniform and easily accessible cell sources, and maybe off-the-shelf therapies. There is a growing pipeline of clinical trials and product development in the field of allogeneic cell therapy as a result of numerous companies refocusing their efforts on this area.

Personalized Medicine and Cell Banking: The field of personalized medicine, which involves customizing treatment plans for each patient according to their specific traits, is becoming more and more popular in the stem cell therapy industry. The process of collecting and preserving human cells for potential therapeutic applications, known as cell banking, is gaining significance. This strategy makes it possible to provide prompt, individualized treatment alternatives, especially in autologous therapies, which use the patient's own cells.

Product Code: SQMIG35H2162

Table of Contents

Executive Summary

  • Market Overview
  • Wheel of Fortune

Research Methodology

  • Information Procurement
  • Secondary & Primary Data Sources
  • Market Size Estimation
  • Market Assumptions & Limitations

Parent Market Analysis

  • Market Overview
  • Market Size
  • Market Dynamics
    • Drivers
    • Opportunities
    • Restraints
    • Challenges

Key Market Insights

  • Technology Analysis
  • Pricing Analysis
  • Supply Chain Analysis
  • Value Chain Analysis
  • Ecosystem of the Market
  • IP Analysis
  • Trade Analysis
  • Startup Analysis
  • Raw Material Analysis
  • Innovation Matrix
  • Pipeline Product Analysis
  • Macroeconomic Indicators
  • Top Investment Analysis
  • Key Success Factor
  • Degree of Competition

Market Dynamics & Outlook

  • Market Dynamics
    • Drivers
    • Opportunities
    • Restraints
    • Challenges
  • Regulatory Landscape
  • Porters Analysis
    • Competitive rivalry
    • Threat of Substitute Products
    • Bargaining Power of Buyers
    • Threat of New Entrants
    • Bargaining Power of Suppliers
  • Skyquest Special Insights on Future Disruptions
    • Political Impact
    • Economic Impact
    • Social Impact
    • Technical Impact
    • Environmental Impact
    • Legal Impact

Global Stem Cell Therapy Market by Therapy

  • Market Overview
  • Autologous
  • and Allogenic

Global Stem Cell Therapy Market by Application

  • Market Overview
  • Regenerative Medicine
  • Drug Discovery and Development

Global Stem Cell Therapy Market Size by Region

  • Market Overview
  • North America
    • USA
    • Canada
  • Europe
    • Germany
    • Spain
    • France
    • UK
    • Rest of Europe
  • Asia Pacific
    • China
    • India
    • Japan
    • South Korea
    • Rest of Asia-Pacific
  • Latin America
    • Brazil
    • Rest of Latin America
  • Middle East & Africa (MEA)
    • GCC Countries
    • South Africa
    • Rest of MEA

Competitive Landscape

  • Top 5 Player Comparison
  • Market Positioning of Key Players, 2021
  • Strategies Adopted by Key Market Players
  • Top Winning Strategies
    • By Development
    • By Company
    • By Year
  • Recent Activities in the Market
  • Key Companies Market Share (%), 2021

Key Company Profiles

  • Novartis AG (Switzerland)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Pfizer Inc. (US)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Mesoblast Limited (Australia)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Celgene Corporation (a subsidiary of Bristol Myers Squibb) (US)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • TiGenix NV (a subsidiary of Takeda Pharmaceutical Company Limited) (Belgium)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Gamida Cell Ltd. (Israel)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Vericel Corporation (US)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Medipost Co., Ltd. (South Korea)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Astellas Pharma Inc. (Japan)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Osiris Therapeutics, Inc. (US)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • NuVasive, Inc. (US)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Cynata Therapeutics Limited (Australia)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Cellular Dynamics International (a subsidiary of FUJIFILM Holdings Corporation) (US)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Lonza Group Ltd. (Switzerland)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Caladrius Biosciences, Inc. (US)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Athersys, Inc. (US)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Cytori Therapeutics, Inc. (US)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Holostem Terapie Avanzate S.r.l. (Italy)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Pluristem Therapeutics Inc. (Israel)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • BioTime, Inc. (US)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
Have a question?
Picture

Jeroen Van Heghe

Manager - EMEA

+32-2-535-7543

Picture

Christine Sirois

Manager - Americas

+1-860-674-8796

Questions? Please give us a call or visit the contact form.
Hi, how can we help?
Contact us!